Defeng Li

2.6k total citations · 1 hit paper
101 papers, 1.8k citations indexed

About

Defeng Li is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Defeng Li has authored 101 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 28 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Defeng Li's work include Gastric Cancer Management and Outcomes (12 papers), Mesoporous Materials and Catalysis (11 papers) and Esophageal and GI Pathology (11 papers). Defeng Li is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Mesoporous Materials and Catalysis (11 papers) and Esophageal and GI Pathology (11 papers). Defeng Li collaborates with scholars based in China, United States and United Kingdom. Defeng Li's co-authors include Jun Yao, Yujie Liang, Lisheng Wang, Meifeng Yang, Haoming Xu, Cheng‐mei Tian, Min‐zheng Zhu, Yuqiang Nie, Feng‐Shou Xiao and Jiangwei Song and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Materials Chemistry.

In The Last Decade

Defeng Li

87 papers receiving 1.8k citations

Hit Papers

Edible exosome-like nanoparticles from portulaca oleracea... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion
    2023 102 citations Min‐zheng Zhu, Haoming Xu et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Defeng Li China 23 770 461 287 228 221 101 1.8k
Ioannis S. Vizirianakis Greece 26 980 1.3× 271 0.6× 168 0.6× 107 0.5× 158 0.7× 136 2.5k
Liping Ye China 28 1.3k 1.7× 313 0.7× 535 1.9× 107 0.5× 89 0.4× 79 2.3k
Wenqing Li China 20 1.0k 1.3× 257 0.6× 230 0.8× 178 0.8× 84 0.4× 74 1.9k
Yuan Wu China 24 676 0.9× 929 2.0× 394 1.4× 50 0.2× 127 0.6× 49 2.5k
Yuan Ding China 24 1.0k 1.3× 563 1.2× 257 0.9× 95 0.4× 76 0.3× 90 2.8k
Min Qiu China 28 1.8k 2.3× 156 0.3× 280 1.0× 245 1.1× 174 0.8× 60 3.0k
Lu Dai China 31 1.2k 1.6× 231 0.5× 391 1.4× 95 0.4× 42 0.2× 138 2.6k
Yue Wang China 27 895 1.2× 137 0.3× 126 0.4× 68 0.3× 110 0.5× 137 2.2k
Weiyu Zhao China 26 1.6k 2.1× 213 0.5× 150 0.5× 243 1.1× 63 0.3× 47 2.7k

Countries citing papers authored by Defeng Li

Since Specialization
Citations

This map shows the geographic impact of Defeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defeng Li more than expected).

Fields of papers citing papers by Defeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defeng Li. The network helps show where Defeng Li may publish in the future.

Co-authorship network of co-authors of Defeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Defeng Li. A scholar is included among the top collaborators of Defeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defeng Li. Defeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Cheng‐mei, Meifeng Yang, Kong Chen, et al.. (2025). Microbiome–Gut–Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders. Journal of Inflammation Research. Volume 18. 13183–13212. 1 indexed citations
2.
3.
Chen, Kong, et al.. (2024). Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy. Journal of Inflammation Research. Volume 17. 5389–5413. 20 indexed citations
4.
Hu, Peng, Cheng‐mei Tian, Kong Chen, et al.. (2024). Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies. Journal of Inflammation Research. Volume 17. 9987–10014. 4 indexed citations
5.
Xu, Haoming, Jing Xu, Min‐zheng Zhu, et al.. (2023). Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. Molecular Therapy — Oncolytics. 30. 193–215. 4 indexed citations
6.
Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases. Stem Cells International. 2023. 1–16. 24 indexed citations
7.
Li, Defeng, Qi Tang, Meifeng Yang, et al.. (2023). Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease. Nanoscale Advances. 5(14). 3575–3588. 29 indexed citations
8.
Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Emerging role of bacterial outer membrane vesicle in gastrointestinal tract. Gut Pathogens. 15(1). 20–20. 37 indexed citations
9.
Zhu, Min‐zheng, Haoming Xu, Yujie Liang, et al.. (2023). Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. Journal of Nanobiotechnology. 21(1). 309–309. 102 indexed citations breakdown →
10.
Liu, Qisong, Defeng Li, Xiaohua Pan, & Yujie Liang. (2023). Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. Journal of Nanobiotechnology. 21(1). 334–334. 91 indexed citations
11.
Lu, Quan, Meifeng Yang, Yujie Liang, et al.. (2022). Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics. SHILAP Revista de lepidopterología. 114 indexed citations
12.
Xu, Haoming, Jing Xu, Meifeng Yang, et al.. (2022). Epigenetic DNA methylation of Zbtb7b regulates the population of double-positive CD4+CD8+ T cells in ulcerative colitis. Journal of Translational Medicine. 20(1). 289–289. 11 indexed citations
13.
Li, Defeng, Meifeng Yang, Haoming Xu, et al.. (2022). Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. Journal of Materials Chemistry B. 10(31). 5853–5872. 65 indexed citations
14.
Xiong, Feng, Wei Cheng, Su Luo, et al.. (2022). Impact of an Abdominal Compression Bandage on the Completion of Colonoscopy for Obese Adults: A Prospective Randomized Controlled Trial. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–8. 7 indexed citations
15.
Li, Defeng, Jun Yao, Zhenglei Xu, et al.. (2022). Oral higher dose prednisolone to prevent stenosis after endoscopic submucosal dissection for early esophageal cancer. World Journal of Clinical Cases. 10(36). 13264–13273. 1 indexed citations
16.
Yang, Meifeng, Feng Xiong, Wei Cheng, et al.. (2021). Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 4032285–4032285. 9 indexed citations
17.
18.
Xu, Zhenglei, Weixiang Luo, Ruiyue Shi, et al.. (2021). MicroRNA-505, Suppressed by Oncogenic Long Non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer. Frontiers in Cell and Developmental Biology. 8. 625056–625056. 17 indexed citations
19.
Yao, Jun, Wei Cheng, Liliangzi Guo, et al.. (2020). Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis. Bioengineered. 11(1). 862–871. 6 indexed citations
20.
Wang, Zhe, Yanqiu Jiang, Yudong Li, et al.. (2019). Synthesis of Porous Fe3C‐Based Composite Beads as Heterogeneous Oxidation Catalysts. Chemistry - A European Journal. 25(16). 4175–4183. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis S. Vizirianakis Breakdown of academic impact, for papers by Liping Ye Breakdown of academic impact, for papers by Wenqing Li Breakdown of academic impact, for papers by Yuan Wu Breakdown of academic impact, for papers by Yuan Ding Breakdown of academic impact, for papers by Min Qiu Breakdown of academic impact, for papers by Lu Dai Breakdown of academic impact, for papers by Yue Wang Breakdown of academic impact, for papers by Weiyu Zhao
Rankless by CCL
2026